Internationally Known Cancer Pharmacologist to Speak at D’Youville
Buffalo, New York – November 15, 2016 – Dr. Susan Band Horwitz, internationally known American biochemist and famous cancer pharmacologist will speak at the D’Youville College School of Pharmacy on Thursday, November 17, at noon.
She is a professor at the Albert Einstein College of Medicine where she holds the Falkenstein Chair in Cancer Research.
She is also the co-chair of the Department of Molecular Pharmacology at the college and played a major role in the development of understanding the complicated mechanisms of certain cancer fighting drugs.
Her biggest contribution to the world of science so far is the work of her team on discovering the unique mechanism of Taxol, also known as Paclitaxel, a drug used to treat ovarian, breast, lung, pancreatic and other cancers. It is now used widely for treatments of these cancers.
Dr. Horwitz’s team was credited with establishing the existence of a novel category on anti-tumor drugs, in which drug molecules bind to microtubules in order in inhibit the further division of cells.
She is the recipient of many awards including the C. Chester Stock Award from Memorial Sloan Kettering Cancer Center, Warren Alpert Foundation Prize from Harvard Medical School, Bristol-Myers Squibb Award for Distinguished Achievement in Cancer Research, American Cancer Society Medal of Honor, and the AACR Award for Lifetime Achievement in Cancer Research.
She graduated from Bryn Mawr College with a degree in Biology, received her doctorate in Biochemistry at Brandeis University, and was a post-doctoral fellow at Tufts University Medical School.
Her appearance at D’Youville is part of the School of Pharmacy Advancement in Pharmacy Research Seminar Series.
Dr. Horwitz will speak the D’Youville Academic Center, Room 411.